FDA Facilitating Innovation of Ophthalmic Devices While Balancing the Need for Safety and Effectiveness-Reference-Cited by-同舟云学术

FDA Facilitating Innovation of Ophthalmic Devices While Balancing the Need for Safety and Effectiveness

Published:2022-04-01 Issue:4 Volume:140 Page:309
ISSN:2168-6165
Container-title:JAMA Ophthalmology
language:en
Short-container-title:JAMA Ophthalmol

Author:

Nguyen Tieuvi¹,Hampton Denise¹,Eydelman Malvina B.¹

Affiliation:

1. Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, Maryland

Publisher

American Medical Association (AMA)

Subject

Ophthalmology

Link

https://jamanetwork.com/journals/jamaophthalmology/articlepdf/2789794/jamaophthalmology_nguyen_2022_vp_220003_1649949487.42083.pdf

Reference10 articles.

1. FDA regulation and approval of medical devices: 1976-2020.;Darrow;JAMA,2021

2. US Food and Drug Administration regulatory programs for innovative technologies.;Brodie;JAMA Ophthalmol,2019

3. Special report: American Academy of Ophthalmology Task Force Consensus Statement for extended depth-of-focus intraocular lenses.;MacRae;Ophthalmology,2017

4. US Food and Drug Administration. Press announcements. Accessed January 10, 2022. https://www.fda.gov/news-events/fda-newsroom/press-announcements

5. US Food and Drug Administration. Workshops & conferences (medical devices). Accessed January 10, 2022. http://wayback.archive-it.org/7993/20180124213834/https://www.fda.gov/MedicalDevices/NewsEvents/WorkshopsConferences/default.htm

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Eyes on the Prize: Decoding the Ophthalmic Product Regulations and Intricacies of the U.S. Food and Drug Administration Approval;Journal of Ocular Pharmacology and Therapeutics;2023-10-01

2. Expedited regulatory product approval in the time of COVID-19;The Ocular Surface;2022-10

3. Eyes on New Product Development;Journal of Ocular Pharmacology and Therapeutics;2022-05-01